anti-CD26 humanized antibodies (Y's Therapeutics)

N/A

Report date: 2025/06/11 10:33:06

Base Information

Drug Nameanti-CD26 humanized antibodies (Y's Therapeutics)
Drug Alias NameAntCycYSCMA (Y`s Therapeutics)huCD26mAbYSCMA-1LYSCMA-GV +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsImmunomodulators
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsGraft vs Host DiseaseKidney NeoplasmsLiver Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesY'S Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesY'S Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsGraft vs Host DiseaseKidney NeoplasmsLiver Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A